Literature DB >> 21454454

Regulatory effects of TLR2 on megakaryocytic cell function.

Lea M Beaulieu1, Elaine Lin, Kristine M Morin, Kahraman Tanriverdi, Jane E Freedman.   

Abstract

TLR2, a functional, inflammatory-related receptor, is known to be expressed on megakaryocytes and platelets and to lead to infection and immune-mediated activation of platelets; however, the role of this receptor in megakaryocytes is not understood. Using Meg-01 cells and mouse megakaryocytes, we found that NFκB, ERK-MAPK, and PI3K/Akt pathways, known downstream pathways of TLRs, are activated by Pam3CSK4, a TLR2-specific ligand. In addition, transcription factors associated with megakaryocyte maturation, GATA-1, NF-E2, and mammalian target of rapamycin (mTOR), are all increased in the presence of Pam3CSK4. The effect of Pam3CSK4 on megakaryocyte maturation was verified by the increase in DNA content and adhesion to extracellular matrix proteins by TLR2-dependent stimulation. In addition, TLR2 stimulation resulted in an increase in reactive oxygen species (ROS) production. Gene expression and protein levels of GP1b, CD41, MCP-1, COX2, NFκB1, and TLR2 were up-regulated in megakaryocytes after TLR2 stimulation through NFκB, PI3K/Akt, and ERK-MAPK pathways. Treatment of wild-type mice with Pam3CSK4 resulted in a return to normal platelet levels and an increase in megakaryocyte maturation, which did not occur in the TLR2(-/-) mice. Therefore, inflammation, through TLR2, can increase maturation and modulate the phenotype of megakaryocytes, contributing to the interrelationship between inflammation and hemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454454      PMCID: PMC3112041          DOI: 10.1182/blood-2010-09-304949

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

Review 1.  Historical review: megakaryopoiesis and thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  Blood       Date:  2008-02-01       Impact factor: 22.113

2.  Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo.

Authors:  Rukhsana Aslam; Edwin R Speck; Michael Kim; Andrew R Crow; K W Annie Bang; Frederick P Nestel; Heyu Ni; Alan H Lazarus; John Freedman; John W Semple
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

3.  Gene expression profiling of LPS-stimulated murine macrophages and role of the NF-kappaB and PI3K/mTOR signaling pathways.

Authors:  S Dos Santos; A-I Delattre; F De Longueville; H Bult; M Raes
Journal:  Ann N Y Acad Sci       Date:  2007-01       Impact factor: 5.691

4.  Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes.

Authors:  Raffaella Guerriero; Isabella Parolini; Ugo Testa; Paola Samoggia; Eleonora Petrucci; Massimo Sargiacomo; Cristiana Chelucci; Marco Gabbianelli; Cesare Peschle
Journal:  J Cell Sci       Date:  2006-01-31       Impact factor: 5.285

Review 5.  Role of phosphoinositide 3-kinase in innate immunity.

Authors:  Kaoru Hazeki; Kiyomi Nigorikawa; Osamu Hazeki
Journal:  Biol Pharm Bull       Date:  2007-09       Impact factor: 2.233

6.  Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release.

Authors:  Sybille Rex; Lea M Beaulieu; David H Perlman; Olga Vitseva; Price S Blair; Mark E McComb; Catherine E Costello; Jane E Freedman
Journal:  Thromb Haemost       Date:  2009-07       Impact factor: 5.249

Review 7.  Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.

Authors:  Elaine Lin; Jane E Freedman; Lea M Beaulieu
Journal:  Cardiovasc Ther       Date:  2009       Impact factor: 3.023

8.  Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase.

Authors:  Price Blair; Sybille Rex; Olga Vitseva; Lea Beaulieu; Kahraman Tanriverdi; Subrata Chakrabarti; Chie Hayashi; Caroline A Genco; Mark Iafrati; Jane E Freedman
Journal:  Circ Res       Date:  2008-12-23       Impact factor: 17.367

9.  Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome.

Authors:  Anne-lie Ståhl; Majlis Svensson; Matthias Mörgelin; Catharina Svanborg; Phillip I Tarr; Jody C Mooney; Sandra L Watkins; Roger Johnson; Diana Karpman
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

10.  15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.

Authors:  Jamie J O'Brien; Sherry L Spinelli; Joanna Tober; Neil Blumberg; Charles W Francis; Mark B Taubman; James Palis; Kathryn E Seweryniak; Jacqueline M Gertz; Richard P Phipps
Journal:  Blood       Date:  2008-08-28       Impact factor: 22.113

View more
  43 in total

1.  Hyaluronan Depolymerization by Megakaryocyte Hyaluronidase-2 Is Required for Thrombopoiesis.

Authors:  Aaron C Petrey; Dana R Obery; Sean P Kessler; Bruno Flamion; Carol A de la Motte
Journal:  Am J Pathol       Date:  2016-07-08       Impact factor: 4.307

2.  Cross-linking Proteomics Indicates Effects of Simvastatin on the TLR2 Interactome and Reveals ACTR1A as a Novel Regulator of the TLR2 Signal Cascade.

Authors:  Abu Hena Mostafa Kamal; Jim J Aloor; Michael B Fessler; Saiful M Chowdhury
Journal:  Mol Cell Proteomics       Date:  2019-06-20       Impact factor: 5.911

3.  Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans.

Authors:  Lea M Beaulieu; Elaine Lin; Eric Mick; Milka Koupenova; Ellen O Weinberg; Carolyn D Kramer; Caroline A Genco; Kahraman Tanriverdi; Martin G Larson; Emelia J Benjamin; Jane E Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-23       Impact factor: 8.311

Review 4.  Emerging roles for platelets as immune and inflammatory cells.

Authors:  Craig N Morrell; Angela A Aggrey; Lesley M Chapman; Kristina L Modjeski
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

Review 5.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

6.  Platelet WDR1 suppresses platelet activity and is associated with cardiovascular disease.

Authors:  Emilie Montenont; Christina Echagarruga; Nicole Allen; Elisa Araldi; Yajaira Suarez; Jeffrey S Berger
Journal:  Blood       Date:  2016-09-08       Impact factor: 22.113

7.  Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets.

Authors:  Anne Zufferey; Edwin R Speck; Kellie R Machlus; Rukhsana Aslam; Li Guo; Mark J McVey; Michael Kim; Rick Kapur; Eric Boilard; Joseph E Italiano; John W Semple
Journal:  Blood Adv       Date:  2017-09-08

Review 8.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

Review 9.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

Review 10.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.